How a tightening labor market impacts Biotech and Pharma Manufacturing
Labor market in Biotech and Pharma With the latest release of employment data from the U.S. Labor Department, it is apparent that, at least in
Category: Cost
Increasing Cost of Innovation. The 3rd Driver of the Foundry Model in the Molecular Diagnostics Industry
Foundry Model Part Three – Increasing Cost of Innovation The third driver that is triggering the growth of the foundry model in Molecular Diagnostics is
The 2nd Driver of the Foundry Model and how it’s shaping the Molecular Diagnostics Industry
Foundry Model Part Two- Leveraging Commonality The second driver that spawned the growth of the foundry model was the ability to Leverage Commonality. By the
Looking to Gain Value in Your Drug Product or IVD? Level-Up Your QC Program
Many organizations view their QC program as a necessary evil- required by regulatory bodies and useful primarily to release product. However, defining and building a
Molecular Diagnostics Industry – Three Reasons why the Foundry Model will Revolutionize Manufacturing
Foundry Model Part One – Keeping Pace in Molecular Diagnostics Innovation The foundry model is poised to fundamentally transform the biotechnology and molecular diagnostics sectors.
Variabilization: Pivotal in your Biotech Reagent and Diagnostic Operations
Variabilization- Â Turn Fixed Cost Into Variable Cost The concept of variabilization, a willful shift from fixed to variable costs, has been around since the late